Mergers & Acquisitions - Rest of the World

Filter

Current filters:

Rest of the World

Popular Filters

Dubai Investments sells 66% stake in Globalpharma to Sanofi

29-06-2014

Dubai Investments PJSC, the leading investment company listed on the Dubai financial market [DFM], has…

GenericsGlobalpharmaMergers & AcquisitionsRest of the WorldSanofi

Recordati finalizes second tranche of Opalia Pharma acquisition

27-05-2014

Following previous announcements about its M&A activity, Italian drugmaker Recordati has now announced…

GenericsMergers & AcquisitionsOpalia PharmaRecordatiRest of the World

Adcock Ingram and CFR Pharma call off merger

Adcock Ingram and CFR Pharma call off merger

10-02-2014

South Africa’s Adcock Ingram and Chile’s largest drugmaker CFR Pharmaceuticals have issued a joint…

Adcock IngramBidvestCFR PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the WorldSouth Africa

CFR Pharma increases bid for Adcock Ingram which is still rejected by PIC

CFR Pharma increases bid for Adcock Ingram which is still rejected by PIC

16-12-2013

Chilean drugmaker CFR Pharmaceuticals has raised its offer price for Adcock Ingram, South Africa’s…

Adcock IngramBidvestMergers & AcquisitionsPharmaceuticalRest of the World

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

Bidvest aims to acquire 34.5% stake in South Africa’s Adcock Ingram, to thwart CFR bid

03-12-2013

South African conglomerate Bidvest, acting on behalf of a consortium including CIH, says it has offered…

Adcock IngramBiovest InternationalCFR PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the WorldSouth Africa

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

Adcock Ingram pleads case for CFR bid; delivers strong revenue growth

28-11-2013

South African drugmaker Adcock Ingram yesterday made the case for accepting a takeover from Chile largest…

Adcock IngramCFR PharmaceuticalsFinancialMergers & AcquisitionsPharmaceuticalRest of the World

GlaxoSmithKline cashes in $694 million of Aspen shares

GlaxoSmithKline cashes in $694 million of Aspen shares

21-11-2013

UK pharma giant GlaxoSmithKline said yesterday that it has agreed to the sale of 28.2 million ordinary…

Aspen PharmacareFinancialGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Abraaj sells stake in Opalia Pharma to Recordati

05-11-2013

The Dubai-based Abraaj Group, an investor operating in global growth markets, has announced its full…

Abraaj GroupDermatologicalsGastro-intestinalsGenericsMergers & AcquisitionsOpalia PharmaRecordatiRespiratory and PulmonaryRest of the World

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Hikma sets up JV for entering Ethiopian pharma market

Hikma sets up JV for entering Ethiopian pharma market

18-09-2013

Jordon-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says that it has signed a 50:50 joint…

GenericsHikma PharmaceuticalsMarkets & MarketingMergers & AcquisitionsMIDROC PharmaceuticalsRest of the World

Teva and Lonza to discontinue their biosimilars collaboration

25-07-2013

Israel-based Teva Pharmaceuticals Industries (NYSE: TEVA), the world's leading generics drugmaker, and…

GenericsLonzaMergers & AcquisitionsRest of the WorldTeva Pharmaceutical Industries

Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal

12-02-2013

The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Hikma to buy Egyptian pharma company for around $20 million

10-01-2013

Fast-growing Jordan-headquartered drugmaker Hikma Pharmaceuticals (LSE: HIK) says it has agreed to acquire…

Egyptian Company for Pharmaceuticals & ChemicGenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalRest of the World

Impax in deal with Perrigo; Cipla eyes South Africa acquisition

22-11-2012

Impax Laboratories (Nasdaq: IPXL) said yesterday that it plans to collaborate with fellow US drugmaker…

CiplaCipla MedproGenericsImpax LaboratoriesMarkets & MarketingMergers & AcquisitionsNorth AmericaPerrigoResearchRest of the World

Hikma adds to stake in Promopharm; gets US appro for argatroban

22-01-2012

Fast-growing Jordan headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has increased its stake…

ArgatrobanCardio-vascularGenericsHikma PharmaceuticalsMergers & AcquisitionsNorth AmericaPharmaceuticalPromopharmRegulationRest of the World

STADA pulls out of part of Grunenthal deal

04-01-2012

German drugmaker STADA Arzneimittel AG (SAZ: GR) says it has exercised its contractual right to withdraw…

EuropeGrunenthalMergers & AcquisitionsPharmaceuticalRest of the WorldSTADA Arzneimittel

Acino pays 80 million euros for Cephalon’s Middle East and African business

18-10-2011

Switzerland-based generic and branded drugmaker Acino (SIX: ACIN) says it has reached agreement to acquire…

Acino PharmaCephalonGenericsMergers & AcquisitionsPharmaceuticalRest of the WorldTeva Pharmaceutical Industries

Hikma enters Moroccan market via $111 million controlling stake in Promopharm

05-10-2011

Jordan-headquartered Hikma Pharmaceuticals (LSE: HIK) says that it has acquired 63.9% of Promopharm (Societe…

GenericsHikma PharmaceuticalsMergers & AcquisitionsPharmaceuticalPromopharmRest of the World

Back to top